USA v. Moffett
Case Number:
1:18-cr-10249
Court:
Nature of Suit:
Judge:
Firms
-
March 22, 2024
Ex-Drug Rep Won't Serve More Time After 1st Circ. Victory
The second sentencing of a former Aegerion Pharmaceuticals Inc. salesman did not add a day in prison to the roughly seven months he served before the First Circuit wiped away his initial conviction on charges he schemed to fraudulently sell the company's cholesterol treatment.
-
March 14, 2024
Feds Seek 20 Mos. For Aegerion Fraud 'Puppet Master'
A pharmaceutical sales representative who gloated about being a "puppet master" for false insurance claims for Aegerion's cholesterol drug should serve 20 months in prison, the U.S. government has told a Boston federal judge.
-
November 21, 2023
Ex-Aegerion Rep Cops To Fraud, Avoiding Trial Redo
A former Aegerion Pharmaceuticals sales representative pled guilty Tuesday in Boston federal court to fraudulently selling the company's cholesterol treatment, ending a nearly 6-year-old case that saw an initial conviction vacated due to a faulty jury charge.
-
November 13, 2023
Ex-Aegerion Rep. Strikes Deal To Avoid 2nd Fraud Trial
A former Aegerion Pharmaceuticals sales representative will plead guilty to his involvement in a scheme to fraudulently sell the company's cholesterol treatment, forgoing a second trial and ending a long-running case that saw his first conviction wiped out due to faulty jury instructions.
-
September 14, 2023
High Court's ID Theft Limits No Help To Drug Rep, Judge Says
A former Aegerion Pharmaceuticals sales representative cannot wield a recent U.S. Supreme Court ruling narrowing prosecutors' use of the identity theft statute to escape charges tied to an alleged scheme to fraudulently sell the company's cholesterol treatment, a Boston federal judge ruled Thursday.
-
August 10, 2023
High Court Ruling No Help To Ex-Aegerion Rep, Feds Say
Federal prosecutors on Wednesday argued that a recent U.S. Supreme Court ruling does not let a former Aegerion Pharmaceuticals sales representative off the hook on identity theft charges tied to his alleged scheme to fraudulently hawk the company's expensive cholesterol treatment.
-
July 27, 2023
Ex-Aegerion Rep Says Top Court Ruling Dooms ID Theft Case
A former Aegerion Pharmaceuticals sales representative who faces a possible second trial on fraud and identity theft charges following a faulty jury instruction is arguing a recent U.S. Supreme Court ruling invalidates part of the government's case.
-
March 23, 2023
Ex-Aegerion Rep Can't Nix Fraud Counts Over Edit, Feds Say
Federal prosecutors told a Boston federal judge that a simple date correction in an updated indictment charging a former Aegerion Pharmaceuticals sales representative with fraud and identity theft isn't nearly enough to warrant tossing the counts from the case.
-
January 10, 2023
Ex-Aegerion Rep In Talks With Feds To Avoid 2nd Fraud Trial
Federal prosecutors are in early talks with a former Aegerion Pharmaceuticals Inc. salesman to resolve allegations that he ran a drug fraud scheme, after the First Circuit tossed his conviction due to an improper jury verdict slip.
-
April 19, 2022
Ex-Aegerion Rep Owes $1.6M To Fraud Victims, Feds Say
A former Aegerion Pharmaceuticals Inc. salesman convicted of fraud should repay $1.6 million to three insurers he duped into paying for the company's cholesterol drug, prosecutors told a Boston federal judge on Tuesday.